FLIDINE MR TABLET

Product Description

FLIDINE MR TABLET
Modified Release Trimetazidine 35mg Cardiac Metabolic Therapy

Product Description:
FLIDINE MR TABLET contains Trimetazidine 35mg (Modified Release), a well-established metabolic agent used in the management of angina pectoris and ischemic heart conditions. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, enhancing cardiac efficiency and reducing chest pain episodes without affecting blood pressure or heart rate.

Key Benefits:

• Supports angina relief and enhances quality of life in patients with stable coronary artery disease

• Improves cardiac metabolic function during ischemic episodes

• Helps maintain cellular energy levels in heart tissues under stress

• Suitable as an adjunct therapy in long-term cardiac care

Recommended Use:
As prescribed by a physician, typically one tablet twice daily.

Target Buyers:
Perfect for cardiologists, hospitals, pharmaceutical distributors, cardiac clinics, medical retailers, and bulk medicine suppliers seeking a reliable, high-demand cardiovascular support product.

Packaging:
Available in tamper-proof blister strips with secure secondary packaging. Custom labeling available for bulk orders.

Stock FLIDINE MR TABLET A trusted name in metabolic anti-anginal therapy for your cardiac care portfolio.
Enquire now for competitive wholesale pricing and distributor collaboration.

#Trimetazidine35mg #FLIDINEMR #AntiAnginalTablet #CardiacCareMedicine #PharmaDistributorsIndia #TradeIndiaPharma #CardiologySupport #BulkPharmaceuticalSupplier